Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957216 · ClinicalTrials.gov registry record · Phase 1
Coenzyme Q10 in Adult-Onset Ataxia
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00957216 is a Phase 1 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1 participants.
The verdict
NCT00957216, a Phase 1 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a Physician-sponsored pilot study, whose purpose it is determine if high-dose oral Coenzyme Q10 (CoQ10) is safe and tolerated in patients with sporadic forms of adult-onset spinocerebellar ataxias (SAOA), a group of degenerative neurological disorders affecting the cerebellum and pathways to and from the cerebellum, with or without additional central nervous system (CNS) manifestations, in the absence of family history of degenerative ataxias.
Interventions
- DRUG Placebo (sugar pill)
- DRUG Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00957216
The ClinicalTrials.gov registry entry for NCT00957216 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo (sugar pill) is the first listed.
NCT00957216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00957216 about?
NCT00957216 is a clinical study titled "Coenzyme Q10 in Adult-Onset Ataxia". This is a Physician-sponsored pilot study, whose purpose it is determine if high-dose oral Coenzyme Q10 (CoQ10) is safe and tolerated in patients with sporadic forms of adult-onset spinocerebellar ataxias (SAOA), a group of degenerative neurological disorders affecting the cerebellum and pathways to...
What is the current status of trial NCT00957216?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2008-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00957216?
The interventions under investigation include: Placebo (sugar pill) (DRUG), Coenzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT00957216?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.